Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression

Journal of Immunology

Volumn 182, Issue 3, 2009, Pages 1247-1252

  Chauhan, Sunil K ^a   El Annan, Jaafar ^a   Ecoiffier, Tatiana ^a   Goyal, Sunali ^a   Zhang, Qiang ^a   Saban, Daniel R ^a   Dana, Reza ^a,b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; GROWTH INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; DRY EYE; EFFECTOR CELL; FEMALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH17 CELL; ANIMAL; AUTOIMMUNE DISEASE; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; CYTOLOGY; DRUG ANTAGONISM; HELPER CELL; HOMEOSTASIS; HOSPITALIZATION; IMMUNOLOGY; INNATE IMMUNITY; LYMPH NODE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRY EYE SYNDROMES; FEMALE; GROWTH INHIBITORS; HOMEOSTASIS; IMMUNITY, INNATE; INTERLEUKIN-17; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 63149101590     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.3.1247     Document Type: Article

References (31)

1. Barabino, S., and M. R. Dana. 2007. Dry eye syndromes. Chem. Immunol. Allergy 92: 176-184.
2. Dana, M. R., and P. Hamrah. 2002. Role of immunity and inflammation in corneal and ocular surface disease associated with dry eye. Adv. Exp. Med. Biol. 506: 729-738.
3. Hemady, R., W. Chu, and C. S. Foster. 1990. Keratoconjunctivitis sicca and corneal ulcers. Cornea 9: 170-173.
4. Pflugfelder, S. C. 2004. Antiinflammatory therapy for dry eye. Am. J. Ophthalmol. 137: 337-342.
5. No authors listed. 2007. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf. 5: 93-107.
6. Miljanović, B., R. Dana, D. A. Sullivan, and D. A. Schaumberg. 2007. Impact of dry eye syndrome on vision-related quality of life. Am. J. Ophthalmol. 143: 409-415.
7. Stern, M. E., J. Gao, T. A. Schwalb, M. Ngo, D. D. Tieu, C. C. Chan, B. L. Reis, S. M. Whitcup, D. Thompson, and J. A. Smith. 2002. Conjunctival T cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. Invest. Ophthalmol. Visual Sci. 43: 2609-2614.
8. De Paiva, C. S., A. L. Villarreal, R. M. Corrales, H. T. Rahman, V. Y. Chang, W. J. Farley, M. E. Stern, J. Y. Niederkorn, D. Q. Li, and S. C. Pflugfelder. 2007. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-γ. Invest. Ophthalmol. Visual Sci. 48: 2553-2560.
9. Niederkorn, J. Y., M. E. Stern, S. C. Pflugfelder, C. S. De Paiva, R. M. Corrales, J. Gao, and K. Siemasko. 2006. Desiccating stress induces T cell-mediated Sjögren's syndrome-like lacrimal keratoconjunctivitis. J. Immunol. 176: 3950-3957.
10. Stevenson, D., J. Tauber, and B. L. Reis. 2000. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial: the Cyclosporin A Phase 2 Study Group. Ophthalmology 107: 967-974.
11. 1 (VLA-4) in dry eye disease. Arch. Ophthalmol. 126: 1695-1699.
12. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
13. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182: 18-32.
14. Steinman, L. 2007. A brief history of Th17, the first major revision in the Th1/ Th2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13: 139-145.
15. McGeachy, M. J., and D. J. Cua. 2008. Th17 cell differentiation: the long and winding road. Immunity 28: 445-453.
16. Barabino, S., L. Shen, L. Chen, S. Rashid, M. Rolando, and M. R. Dana. 2005. The controlled-environment chamber: a new mouse model of dry eye. Invest. Ophthalmol. Visual Sci. 46: 2766-2771.
17. Rashid, S., Y. Jin, T. Ecoiffier, S. Barabino, D. A. Schaumberg, and M. R. Dana. 2008. Topical ω-3 and ω-6 fatty acids for treatment of dry eye. Arch. Ophthalmol. 126: 219-225.
18. Lemp, M. A. 1995. Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J. 21: 221-232.
19. + regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis. J. Neuroimmunol. 191: 51-60.
20. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199: 971-979.
21. Ehrenstein, M. R., J. G. Evans, A. Singh, S. Moore, G. Warnes, D. A. Isenberg, and C. Mauri. 2004. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J. Exp. Med. 200: 277-285.
22. Korn, T., J. Reddy, W. Gao, E. Bettelli, A. Awasthi, T. R. Petersen, B. T. Bäckström, R. A. Sobel, K. W. Wucherpfennig, T. B. Strom, M. Oukka, and V. K. Kuchroo. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13: 423-431.
23. Nistala, K., H. Moncrieffe, K. R. Newton, H. Varsani, P. Hunter, and L. R. Wedderburn. 2008. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum. 58: 875-887.
24. Yang, X. O., R. Nurieva, G. J. Martinez, H. S. Kang, Y. Chung, B. P. Pappu, B. Shah, S. H. Chang, K. S. Schluns, S. S. Watowich, et al. 2008. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29: 44-56.
25. Pflugfelder, S. C., D. Jones, Z. Ji, A. Afonso, and D. Monroy. 1999. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr. Eye Res. 19: 201-211.
26. Solomon, A., D. Dursun, Z. Liu, Y. Xie, A. Macri, and S. C. Pflugfelder. 2001. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest. Ophthalmol. Visual Sci. 42: 2283-2292.
27. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 441: 235-238.
28. - T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-β. J. Immunol. 178: 6725-6729.
29. Hofstetter, H. H., S. M. Ibrahim, D. Koczan, N. Kruse, A. Weishaupt, K. V. Toyka, and R. Gold. 2005. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell. Immunol. 237: 123-130.
30. Koenders, M. I., E. Lubberts, B. Oppers-Walgreen, L. van den Bersselaar, M. M. Helsen, F. E. Di Padova, A. M. Boots, H. Gram, L. A. Joosten, and W. B. van den Berg. 2005. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am. J. Pathol. 167: 141-149.
31. Yao, Z., W. C. Fanslow, M. F. Seldin, A. M. Rousseau, S. L. Painter, M. R. Comeau, J. I. Cohen, and M. K. Spriggs. 1995. Herpesvirus saimiri encodes a new cytokine: IL-17, which binds to a novel cytokine receptor. Immunity 3: 811-821.